The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.
Open accessAbstract
Despite significant improvements in the primary success rate of the medical and surgical treatments for atherosclerotic disease, including angioplasty, bypass grafting, and endarterectomy, secondary failure due to late restenosis continues to occur in 30-50% of individuals. Restenosis and the later stages in atherosclerotic lesions are due to a complex series of fibroproliferative responses to vascular injury involving potent growth-regulatory molecules (such as platelet-derived growth factor and basic fibroblast growth factor) and resulting in vascular smooth muscle cell (VSMC) proliferation, migration, and neointimal accumulation. We show here, based on experiments with both taxol and deuterium oxide, that microtubules are necessary for VSMCs to undergo the multiple transformations contributing to the development of the neointimal fibroproliferative lesion. Taxol was found to interfere both with platelet-derived growth factor-stimulated VSMC migration and with VSMC migration and with VSMC proliferation, at nanomolar levels in vitro. In vivo, taxol prevented medial VSMC proliferation and the neointimal VSMC accumulation in the rat carotid artery after balloon dilatation and endothelial denudation injury. This effect occurred at plasma levels approximately two orders of magnitude lower than that used clinically to treat human malignancy (peak levels achieved in this model were approximately 50-60 nM). Taxol may therefore be of therapeutic value in preventing human restenosis with minimal toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
The biology of platelet-derived growth factor
Ross, R., Raines, E. W., & Bowen-Pope, D. F. (1986) · Cell · doi:10.1016/0092-8674(86)90733-6 · Cited by 2,008
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Albini, A., Iwamoto, Y., Hk, K., Gr, M., Aaronson, S. A., Jm, K., & McEwan, R. N. (1987) · PubMed · Cited by 1,778
Basement membrane complexes with biological activity
Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., & Martin, G. R. (1986) · Biochemistry · doi:10.1021/bi00350a005 · Cited by 1,502
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Self-citationTaxol: A Novel Investigational Antimicrotubule Agent
Rowinsky, E. K., Cazenave, L. A., & Donehower, R. C. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.15.1247 · Cited by 1,090
Self-citationInhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Edelman, G. M. (1976) · Science · doi:10.1126/science.769162 · Cited by 1,054
Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D. E., & Vlodavsky, I. (1988) · PubMed · Cited by 969
PLATELET-DERIVED GROWTH FACTOR
Ross, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92760-8 · Cited by 940
Harker, L. A., Ross, R., Slichter, S. J., & Scott, C. R. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108520 · Cited by 933
THE IMPACT OF NATIONAL CANCER ACT
(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797 · Cited by 796
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
Holmes, F. A., Walters, R. S., Theriault, R. L., Buzdar, A. U., Frye, D. K., Hortobagyi, G. N., Forman, A. D., Newton, L. K., & Raber, M. N. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797-a · Cited by 746
Two Classes of PDGF Receptor Eecognize Different Isoforms of PDGF
Hart, C. E., Forstrom, J. W., Kelly, J. D., Seifert, R. A., Smith, R. A., Ross, R., Murray, M. J., & Bowen-Pope, D. F. (1988) · Science · doi:10.1126/science.2836952 · Cited by 580
Gianni, L., Kearns, C. M., Giani, A., Capri, G., Viganó, L., Lacatelli, A., Bonadonna, G., & Egorin, M. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.180 · Cited by 553
Cell proliferation in human coronary arteries.
Gordon, D., Reidy, M. A., Benditt, E. P., & Schwartz, S. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4600 · Cited by 532
Platelet-derived growth factor: mechanism of action and possible in vivo function.
Heldin, C. H., & Westermark, B. (1990) · Cell Regulation · doi:10.1091/mbc.1.8.555 · Cited by 486
Regulation of microtubule dynamics by cdc2 protein kinase in cell-free extracts of Xenopus eggs
Verde, F., Labbé, J.-C., Dorée, M., & Karsenti, E. (1990) · Nature · doi:10.1038/343233a0 · Cited by 441
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
Rowinsky, E. K., Donehower, R. C., Jones, R. J., & Tucker, R. W. (1988) · PubMed · Cited by 368
Self-citationO'Brien, E. R., Alpers, C. E., Stewart, D. K., Ferguson, M., Tran, N., Gordon, D., Benditt, E. P., Hinohara, T., Simpson, J. B., & Schwartz, S. M. (1993) · Circulation Research · doi:10.1161/01.res.73.2.223 · Cited by 361
Stemerman, M. B., & Ross, R. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.4.769 · Cited by 323
Characterization of microtubule assembly in porcine brain extracts by viscometry
Olmsted, J. B., & Borisy, G. G. (1973) · Biochemistry · doi:10.1021/bi00745a037 · Cited by 317
Pauly, R. R., Passaniti, A., Bilato, C., Monticone, R., Cheng, L., Papadopoulos, N., Gluzband, Y. A., Smith, L., Weinstein, C., & Lakatta, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.1.41 · Cited by 313
Self-citationHuizing, M. T., Keung, A. C., Rosing, H., van der Kuij, V, ten Bokkel Huinink, W. W., Mandjes, I. M., Dubbelman, A. C., Pinedo, H. M., & Beijnen, J. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2127 · Cited by 308
Friedman, R. J., Stemerman, M. B., Wenz, B., Moore, S., Gauldie, J., Gent, M., Tiell, M. L., & Spaet, H. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108872 · Cited by 295
Einzig, A. I., Wiernik, P. H., Sasloff, J., Runowicz, C. D., & Goldberg, G. L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.11.1748 · Cited by 263
Klagsbrun, M., & Edelman, E. R. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.3.269 · Cited by 227
Sjölund, M., Hedin, U., Sejersen, T., Heldin, C., & Thyberg, J. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.2.403 · Cited by 204
Crossin, K. L., & Carney, D. H. (1981) · Cell · doi:10.1016/0092-8674(81)90270-1 · Cited by 203
A reassessment of endothelial injury and arterial lesion formation.
Reidy, M. A. (1985) · PubMed · Cited by 196
Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
Rowinsky, E. K., Burke, P. J., Karp, J. E., Tucker, R. W., Ettinger, D. S., & Donehower, R. C. (1989) · PubMed · Cited by 196
Self-citationA phase II study of taxol in patients with malignant melanoma
Einzig, A. I., Hochster, H., Wiernik, P. H., Trump, D. L., Dutcher, J. P., Garowski, E., Sasloff, J., & Smith, T. J. (1991) · Investigational New Drugs · doi:10.1007/bf00194546 · Cited by 180
Lindner, V, Olson, N. E., Clowes, A. W., & Reidy, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116085 · Cited by 159
Ability of the c- mos Product to Associate with and Phosphorylate Tubulin
Zhou, R., Oskarsson, M. S. Z., Paules, R. S., Schulz, N. T., Cleveland, D. W., & Woude, G. F. V. (1991) · Science · doi:10.1126/science.1825142 · Cited by 129
Biological Effects of Deuterium.
Wilson, L. G. (1964) · The Yale Journal of Biology and Medicine · Cited by 120
Longnecker, S. M., Donehower, R. C., Cates, A. E., Chen, T. L., Brundrett, R. B., Grochow, L. B., Ettinger, D. S., & Colvin, M. (1987) · PubMed · Cited by 112
Development of polyploidization in taxol-resistant human leukemia cells in vitro.
Roberts, J. R., Allison, D. C., Donehower, R. C., & Rowinsky, E. K. (1990) · PubMed · Cited by 100
Self-citationExperimental models that mimic the differentiation and dedifferentiation of vascular cells.
Rr, P., Passaniti, A., Crow, M. T., Jl, K., Papadopoulos, N. M., Monticone, R. E., Lakatta, E. G., & Gr, M. (1992) · PubMed · Cited by 95
Self-citationTaxol: pharmacology, metabolism and clinical implications.
Rowinsky, E. K., Wright, M., Monsarrat, B., Lesser, G. J., & Rc, D. (1993) · PubMed · Cited by 80
Self-citationTeng, M.-H., Bartholomew, J. C., & Bissell, M. J. (1977) · Nature · doi:10.1038/268739a0 · Cited by 78
Dustin, P. (1980) · Scientific American · doi:10.1038/scientificamerican0880-66 · Cited by 77
Otto, A. M., Ulrich, M. O., Zumbé, A., & de Asúa, L. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3063 · Cited by 47
Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells.
Maxwell, S. A., Ames, S. K., Sawai, E. T., Decker, G. L., Cook, R. G., & Butel, J. S. (1991) · PubMed · Cited by 44
Effect of microtubular antagonists on lymphocyte mitogenesis
Rasmussen, S. A., & DAVIS, R. P. (1977) · Nature · doi:10.1038/269249a0 · Cited by 21
Cited by
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O'Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032441 · Cited by 2,749
Colombo, A., Drzewiecki, J., Banning, A., Grube, E., Hauptmann, K., Silber, S., Dudek, D., Fort, S., Schiele, F., Zmudka, K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086926.62288.a6 · Cited by 1,016
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Lüscher, T. F., Steffel, J., Eberli, F. R., Joner, M., Nakazawa, G., Tanner, F. C., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.106.675934 · Cited by 906
Axel, D. I., Kunert, W., Göggelmann, C., Oberhoff, M., Herdeg, C., Küttner, A., Wild, D. H., Brehm, B. R., Riessen, R., Köveker, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.636 · Cited by 784
Molecular Basis of Restenosis and Drug-Eluting Stents
Costa, M. A., & Simon, D. I. (2005) · Circulation · doi:10.1161/01.cir.0000163587.36485.a7 · Cited by 510
Metadata
- Authors
- Sollott, S. J., Cheng, L., Pauly, R. R., Jenkins, G. M., Monticone, R. E., Kuzuya, M., Froehlich, J. P., Crow, M. T., Lakatta, E. G., & Rowinsky, E. K.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-04-01
- Volume
- 95
- Issue
- 4
- Pages
- 1869-1876
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2051699557
- Cited by
- 253
- References
- 49
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.